C3, C5a and anti-acetylcholine receptor antibody as severity biomarkers in myasthenia gravis.
Florencia AguirreAnalisa ManinVictoria C FernandezMariano E JustoJuliana LeoniMariela L PazAndres M VillaPublished in: Therapeutic advances in neurological disorders (2020)
AChR-ab titers and C5a levels could potentially be considered markers of severity in patients with MG.
Keyphrases